MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III

per Campbell, Kirsteen J., White, Robert J.
Publicat 2014

Targeting BCL-2 regulated apoptosis in cancer

per Campbell, Kirsteen J., Tait, Stephen W. G.
Publicat a Open Biol (2018)

Differential regulation of NF-κB activation and function by topoisomerase II inhibitors

per Campbell, Kirsteen J, O'Shea, John M, Perkins, Neil D
Publicat 2006

The p53-inhibitor Pifithrin-α inhibits Firefly Luciferase activity in vivo and in vitro

per Rocha, Sonia, Campbell, Kirsteen J, Roche, Kevin C, Perkins, Neil D
Publicat 2003

Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor

per Rocha, Sonia, Garrett, Michelle D, Campbell, Kirsteen J, Schumm, Katie, Perkins, Neil D
Publicat 2005

Mnt modulates Myc-driven lymphomagenesis

per Campbell, Kirsteen J, Vandenberg, Cassandra J, Anstee, Natasha S, Hurlin, Peter J, Cory, Suzanne
Publicat a Cell Death Differ (2017)

Cezanne regulates E2F1-dependent HIF2α expression

per Moniz, Sonia, Bandarra, Daniel, Biddlestone, John, Campbell, Kirsteen J., Komander, David, Bremm, Anja, Rocha, Sonia
Publicat a J Cell Sci (2015)

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice

per Anstee, Natasha S, Vandenberg, Cassandra J, Campbell, Kirsteen J, Hughes, Peter D, O'Reilly, Lorraine A, Cory, Suzanne
Publicat a Cell Death Differ (2017)

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance

per Campbell, Kirsteen J., Bath, Mary L., Turner, Marian L., Vandenberg, Cassandra J., Bouillet, Philippe, Metcalf, Donald, Scott, Clare L., Cory, Suzanne
Publicat 2010

MCL-1 is a prognostic indicator and drug target in breast cancer

per Campbell, Kirsteen J., Dhayade, Sandeep, Ferrari, Nicola, Sims, Andrew H., Johnson, Emma, Mason, Susan M., Dickson, Ashley, Ryan, Kevin M., Kalna, Gabriela, Edwards, Joanne, Tait, Stephen W. G., Blyth, Karen
Publicat a Cell Death Dis (2018)

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas

per Liko, Dritan, Mitchell, Louise, Campbell, Kirsteen J., Ridgway, Rachel A., Jones, Carolyn, Dudek, Kate, King, Ayala, Bryson, Sheila, Stevenson, David, Blyth, Karen, Strathdee, Douglas, Morton, Jennifer P., Bird, Thomas G., Knight, John R. P., Willis, Anne E., Sansom, Owen J.
Publicat a Cell Death Differ (2019)

Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability

per Woodward, Jessica, Taylor, Gillian C., Soares, Dinesh C., Boyle, Shelagh, Sie, Daoud, Read, David, Chathoth, Keerthi, Vukovic, Milica, Tarrats, Nuria, Jamieson, David, Campbell, Kirsteen J., Blyth, Karen, Acosta, Juan Carlos, Ylstra, Bauke, Arends, Mark J., Kranc, Kamil R., Jackson, Andrew P., Bickmore, Wendy A., Wood, Andrew J.
Publicat a Genes Dev (2016)

Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1

per Croker, Ben A., O'Donnell, Joanne A., Nowell, Cameron J., Metcalf, Donald, Dewson, Grant, Campbell, Kirsteen J., Rogers, Kelly L., Hu, Yifang, Smyth, Gordon K., Zhang, Jian-Guo, White, Michael, Lackovic, Kurt, Cengia, Louise H., O'Reilly, Lorraine A., Bouillet, Philippe, Cory, Suzanne, Strasser, Andreas, Roberts, Andrew W.
Publicat 2011

Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

per Mérino, Delphine, Khaw, Seong L., Glaser, Stefan P., Anderson, Daniel J., Belmont, Lisa D., Wong, Chihunt, Yue, Peng, Robati, Mikara, Phipson, Belinda, Fairlie, Walter D., Lee, Erinna F., Campbell, Kirsteen J., Vandenberg, Cassandra J., Cory, Suzanne, Roberts, Andrew W., Ludlam, Mary J. C., Huang, David C. S., Bouillet, Philippe
Publicat 2012

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

per Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicat a Oncogene (2019)

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

per Loveridge, Carolyn J., Slater, Sarah, Campbell, Kirsteen J., Nam, Noor A., Knight, John, Ahmad, Imran, Hedley, Ann, Lilla, Sergio, Repiscak, Peter, Patel, Rachana, Salji, Mark, Fleming, Janis, Mitchell, Louise, Nixon, Colin, Strathdee, Douglas, Neilson, Matthew, Ntala, Chara, Bryson, Sheila, Zanivan, Sara, Edwards, Joanne, Robson, Craig N., Goodyear, Carl S., Blyth, Karen, Leung, Hing Y.
Publicat a Oncogene (2019)